Reference Source

Due for re-check: the scheduled review date of 2026-09-04 has passed. Every value below still carries the source it was taken from and the passage that states it — check it against the link.

0169-4060-13 · Liraglutide Injection · Novo Nordisk, Inc.

What is the package ndc for 0169-4060-13 · Liraglutide Injection · Novo Nordisk, Inc.?

For 0169-4060-13 · Liraglutide Injection · Novo Nordisk, Inc., package ndc is 0169-4060-13; generic name is Liraglutide Injection; manufacturer is Novo Nordisk, Inc; status is Current; availability now is Limited Availability, recorded from its source on 2026-09-01.

"initial_posting_date": "07/18/2023", "package_ndc": "0169-4060-13", "generic_name": "Liraglutide Injection", "contact_info": "833-493-4689", "availability": "Limited Availability", "related_info": "Estimated shortage duration: TBD"

api.fda.gov, retrieved 2026-09-01

Package NDC
0169-4060-13 verified
Generic name
Liraglutide Injection verified
Manufacturer
Novo Nordisk, Inc. verified
Status
Current verified
Availability now
Limited Availability verified
FDA note
Estimated shortage duration: TBD verified
Initial posting date
07/18/2023 verified
Last update date
08/25/2026 verified
Days in shortage
1141 our reading
Reason for shortage
Delay in shipping of the drug verified
Dosage form
Injection verified
Therapeutic category
Endocrinology/Metabolism verified
Sourceapi.fda.gov
Verified
Review by
DatasetFDA drug shortage duration tracker

Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.

Where each value comes from

The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.

Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category

"update_date": "08/25/2026", "therapeutic_category": [ "Endocrinology/Metabolism" ], "dosage_form": "Injection", "presentation": "Victoza, Injection, 6 mg/1 mL (NDC 0169-4060-13)", "company_name": "Novo Nordisk, Inc.", "shortage_reason": "Delay in shipping of the drug", "status": "Current"

— all from api.fda.gov, retrieved 2026-09-01

Source

Last verified against source: . Due for re-check by . This page as Markdown · OKF bundle · full dataset as JSON.